Wenshuang Sun

The Key Laboratory Of Advanced Interdisciplinary Studies, The First Affiliated Hospital Of Guangzhou Medical University & Guangdong Provincial Key Laboratory Of Protein Modification And Diseases
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

HERC4 synergizes with USP16 to promote lung adenocarcinoma growth by augmenting protein translation via stabilizing RPS15.

HERC4 synergizes with USP16 to promote lung adenocarcinoma growth by augmenting protein translation via stabilizing RPS15.

Journal: Oncogene
Published: January 19, 2026

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

Journal: Oncogene
Published: November 06, 2025

WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

Journal: Oncogene
Published: February 26, 2025

Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.

Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.

Journal: Experimental cell research
Published: September 27, 2024

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

Journal: Pharmacological research
Published: September 21, 2024

The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.

The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.

Journal: Oncogene
Published: July 23, 2024

SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.

SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.

Journal: Cellular & molecular biology letters
Published: April 11, 2024

HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.

HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 29, 2023

A SIX1 degradation inducer blocks excessive proliferation of prostate cancer.

A SIX1 degradation inducer blocks excessive proliferation of prostate cancer.

Journal: International journal of biological sciences
Published: October 08, 2021

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.

Journal: Cell death & disease
Published: June 23, 2021

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling.

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling.

Journal: Frontiers in oncology
Published: April 22, 2021

USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.

USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026